NCT02316730View on ClinicalTrials.gov

A Bioequivalence Study of Sanchi-Tongshu Capsule (Enteric Coated Pellets)

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
DRUG

Sanchi-Tongshu Capsule (Enteric coated pellets)

Take 0.7g (2 Capsules) of test preparation orally.

DRUG

Sanchi-Tongshu Capsule

Take 0.4g (2 Capsules) of reference preparation orally.

Trial Locations (1)

610000

West China Second University Hospital, Chengdu

All Listed Sponsors
collaborator

West China Second University Hospital

OTHER

collaborator

Sichuan University

OTHER

lead

Pharmaceutical Factory of Chengdu HuaSun Group Inc., Ltd.

INDUSTRY

NCT02316730 - A Bioequivalence Study of Sanchi-Tongshu Capsule (Enteric Coated Pellets) | Biotech Hunter | Biotech Hunter